Ugandan officials are gearing up to introduce a trial vaccine in an effort to contain an outbreak of Ebola in the capital city of Kampala, according to a top health official. The vaccine, aimed at combating the Sudan strain of Ebola, is currently in the research and development phase, with over 2,000 doses set to be deployed.
The World Health Organization has pledged its support to Uganda's response efforts by providing access to 2,160 doses of the trial vaccine. Research teams are on the ground collaborating with surveillance teams while awaiting regulatory approvals for the vaccine deployment.
